The combination of low muscle mass (LMM) and low muscle density (LMD) is associated with shorter survival in patients with diffuse large B-cell lymphoma (DLBCL), according to a study published online in Leukemia & Lymphoma.
Researchers examined the association between LMM and LMD and survival in patients with DLBCL. A total of 164 DLBCL patients underwent computed tomography-based measurement of muscle prior to chemo-immunotherapy.